Sanofi Aktie
94,98
EUR
+2,05
EUR
+2,21
%
93,17
EUR
+0,09
EUR
+0,10
%
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 100,00 EUR | +7,33% | 28.04.2025 | |
| UBS AG | 115,00 EUR | +23,43% | 28.04.2025 | |
| DZ BANK | - | - | 25.04.2025 | |
| Goldman Sachs Group Inc. | 117,00 EUR | +25,58% | 25.04.2025 | |
| Barclays Capital | 125,00 EUR | +34,16% | 24.04.2025 | |
| Bernstein Research | 114,00 EUR | +22,36% | 24.04.2025 | |
| JP Morgan Chase & Co. | 110,00 EUR | +18,06% | 24.04.2025 | |
| Jefferies & Company Inc. | 120,00 EUR | +28,80% | 09.04.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 120,00 EUR | +28,80% | 05.03.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 137,65 GBP | +29,64% |
| Bayer | 1 | 8 | 0 | 25,03 EUR | +8,03% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +26,61% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,90 EUR | +33,03% |
| GSK PLC Registered Shs | 2 | 5 | 1 | 16,53 GBP | +15,43% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 179,43 EUR | +45,82% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +142,02% |
| MorphoSys | 0 | 1 | 0 | 68,00 EUR | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 100,25 CHF | +6,41% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 29,20 USD | +22,74% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +23,56% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |